성인용 백신 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Adult Vaccine Trends and Forecast

The future of the global adult vaccine market looks promising with opportunities in the private healthcare firm and government hospital markets. The global adult vaccine market is expected to reach an estimated $24.4 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are growing cases of contagious diseases and supportive government initiatives to spread awareness about the importance of vaccination among population.

A more than 150-page report is developed to help in your business decisions.

Adult Vaccine by Segment

The study includes a forecast for the global adult vaccine by technology, vaccine type, end use, and region.

Adult Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others

Adult Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

• Monovalent
• Multivalent

Adult Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Private Healthcare Firms
• Government Hospitals

Adult Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Adult Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adult vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adult vaccine companies profiled in this report include-

• Glaxosmithkline
• Merck & Co
• Sanofi
• Johnson & Johnson
• Serum Institute India
• Astrazeneca
• Novartis

Adult Vaccine Market Insights

Lucintel forecasts that multivalent is expected to witness higher growth over the forecast period due to its broader application to protect against bacterial and viral illnesses.

Within this market, private healthcare firm is expected to witness higher growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to presence of strong government support for immunization programs and existence of robust healthcare infrastructure in the region.

Features of the Global Adult Vaccine Market

Market Size Estimates: Adult vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adult vaccine market size by technology, vaccine type, end use, and region in terms of value ($B).

Regional Analysis: Adult vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, vaccine types, end uses, and regions for the adult vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adult vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the adult vaccine market size?

Answer: The global adult vaccine market is expected to reach an estimated $24.4 billion by 2030.

Q.2 What is the growth forecast for adult vaccine market?

Answer: The global adult vaccine market is expected to grow with a CAGR of 6.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the adult vaccine market?

Answer: The major drivers for this market are growing cases of contagious diseases and supportive government initiatives to spread awareness about the importance of vaccination among population.

Q4. What are the major segments for adult vaccine market?

Answer: The future of the adult vaccine market looks promising with opportunities in the private healthcare firm and government hospital markets.

Q5. Who are the key adult vaccine market companies?

Answer: Some of the key adult vaccine companies are as follows:

• Glaxosmithkline
• Merck & Co
• Sanofi
• Johnson & Johnson
• Serum Institute India
• Astrazeneca
• Novartis

Q6. Which adult vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that multivalent is expected to witness higher growth over the forecast period due to its broader application to protect against bacterial and viral illnesses.

Q7. In adult vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of strong government support for immunization programs and existence of robust healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the adult vaccine market by technology (live attenuated, inactivated, subunit, toxoid, conjugate , and others), vaccine type (monovalent and multivalent), end use (private healthcare firms and government hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adult Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Adult Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Adult Vaccine Market by Technology
  • 3.3.1: Live Attenuated
  • 3.3.2: Inactivated
  • 3.3.3: Subunit
  • 3.3.4: Toxoid
  • 3.3.5: Conjugate
  • 3.3.6: Others
• 3.4: Global Adult Vaccine Market by Vaccine Type
  • 3.4.1: Monovalent
  • 3.4.2: Multivalent
• 3.5: Global Adult Vaccine Market by End Use
  • 3.5.1: Private Healthcare Firms
  • 3.5.2: Government Hospitals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Adult Vaccine Market by Region
• 4.2: North American Adult Vaccine Market
  • 4.2.1: North American Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
  • 4.2.2: North American Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
• 4.3: European Adult Vaccine Market
  • 4.3.1: European Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
  • 4.3.2: European Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
• 4.4: APAC Adult Vaccine Market
  • 4.4.1: APAC Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
  • 4.4.2: APAC Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
• 4.5: ROW Adult Vaccine Market
  • 4.5.1: ROW Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
  • 4.5.2: ROW Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Adult Vaccine Market by Technology
  • 6.1.2: Growth Opportunities for the Global Adult Vaccine Market by Vaccine Type
  • 6.1.3: Growth Opportunities for the Global Adult Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Adult Vaccine Market by Region
• 6.2: Emerging Trends in the Global Adult Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Adult Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adult Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Glaxosmithkline
• 7.2: Merck & CO
• 7.3: Sanofi
• 7.4: Johnson & Johnson
• 7.5: Serum institute India
• 7.6: AstraZeneca
• 7.7: Novartis